BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 27085539)

  • 1. Systemic Treatment of Pediatric Psoriasis: A Review.
    Napolitano M; Megna M; Balato A; Ayala F; Lembo S; Villani A; Balato N
    Dermatol Ther (Heidelb); 2016 Jun; 6(2):125-42. PubMed ID: 27085539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psoriasis in Children: A Review.
    ; Balato A; Scalvenzi M; Cirillo T; Gallo L; Ayala F; Balato N
    Curr Pediatr Rev; 2015; 11(1):10-26. PubMed ID: 25938378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of psoriasis in adolescence.
    Fotiadou C; Lazaridou E; Ioannides D
    Adolesc Health Med Ther; 2014; 5():25-34. PubMed ID: 24729738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pediatric Psoriasis: From New Insights into Pathogenesis to Updates on Treatment.
    Kim HO; Kang SY; Kim JC; Park CW; Chung BY
    Biomedicines; 2021 Aug; 9(8):. PubMed ID: 34440145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biologics in pediatric psoriasis - efficacy and safety.
    Dogra S; Mahajan R
    Expert Opin Drug Saf; 2018 Jan; 17(1):9-16. PubMed ID: 29022425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultraviolet Phototherapy Management of Moderate-to-Severe Plaque Psoriasis: An Evidence-Based Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2009; 9(27):1-66. PubMed ID: 23074532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological Treatments for Pediatric Psoriasis: State of the Art and Future Perspectives.
    Diotallevi F; Simonetti O; Rizzetto G; Molinelli E; Radi G; Offidani A
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic Treatment of Recalcitrant Pediatric Psoriasis: A Case Series and Literature Review.
    Garber C; Creighton-Smith M; Sorensen EP; Dumont N; Gottlieb AB
    J Drugs Dermatol; 2015 Aug; 14(8):881-6. PubMed ID: 26267734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FDA Approved Biologics: Can Etanercept and Ustekinumab be Considered a First-Line Systemic Therapy for Pediatric/Adolescents in Moderate to Severe Psoriasis? A Systematic Review.
    Aslam N; Saleem H; Murtazaliev S; Quazi SJ; Khan S
    Cureus; 2020 Aug; 12(8):e9812. PubMed ID: 32953323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
    Sbidian E; Chaimani A; Garcia-Doval I; Doney L; Dressler C; Hua C; Hughes C; Naldi L; Afach S; Le Cleach L
    Cochrane Database Syst Rev; 2021 Apr; 4(4):CD011535. PubMed ID: 33871055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
    Sbidian E; Chaimani A; Afach S; Doney L; Dressler C; Hua C; Mazaud C; Phan C; Hughes C; Riddle D; Naldi L; Garcia-Doval I; Le Cleach L
    Cochrane Database Syst Rev; 2020 Jan; 1(1):CD011535. PubMed ID: 31917873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic challenges in managing pediatric psoriasis.
    Goenaga-Vázquez Y; Lauck KC; Hebert AA
    Int J Womens Dermatol; 2021 Jun; 7(3):314-318. PubMed ID: 34222589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
    Sbidian E; Chaimani A; Garcia-Doval I; Do G; Hua C; Mazaud C; Droitcourt C; Hughes C; Ingram JR; Naldi L; Chosidow O; Le Cleach L
    Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011535. PubMed ID: 29271481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pediatric Psoriasis.
    Relvas M; Torres T
    Am J Clin Dermatol; 2017 Dec; 18(6):797-811. PubMed ID: 28540590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management Strategies for Pediatric Moderate-to-Severe Plaque Psoriasis: Spotlight on Biologics.
    Ruggiero A; Portarapillo A; Megna M; Patruno C; Napolitano M
    Pediatric Health Med Ther; 2023; 14():435-451. PubMed ID: 38024562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Impact of Inflammatory Bowel Disease in Canada 2018: Children and Adolescents with IBD.
    Carroll MW; Kuenzig ME; Mack DR; Otley AR; Griffiths AM; Kaplan GG; Bernstein CN; Bitton A; Murthy SK; Nguyen GC; Lee K; Cooke-Lauder J; Benchimol EI
    J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S49-S67. PubMed ID: 31294385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adalimumab in children and adolescents with severe plaque psoriasis: a safety evaluation.
    Zangrilli A; Bavetta M; Bianchi L
    Expert Opin Drug Saf; 2020 Apr; 19(4):433-438. PubMed ID: 32250180
    [No Abstract]   [Full Text] [Related]  

  • 18. Acupuncture as a Complementary Method of Traditional Psoriasis Treatment: Myth or Reality?
    Mahović D; Mrsić F
    Acta Dermatovenerol Croat; 2016 Aug; 24(3):221-2. PubMed ID: 27663925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pediatric psoriasis: Evolving perspectives.
    Eichenfield LF; Paller AS; Tom WL; Sugarman J; Hebert AA; Friedlander SF; Siegfried E; Silverberg N; Cordoro KM
    Pediatr Dermatol; 2018 Mar; 35(2):170-181. PubMed ID: 29314219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical and Oral Therapies for Childhood Atopic Dermatitis and Plaque Psoriasis.
    Frantz T; Wright EG; Balogh EA; Cline A; Adler-Neal AL; Feldman SR
    Children (Basel); 2019 Nov; 6(11):. PubMed ID: 31694234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.